Corcept Therapeutics Inc CORT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:52 PM EST
25.22quote price arrow down-0.34 (-1.35%)
Volume
330,964
52 week range
9.70 - 31.18

...

Loading . . .

KEY STATS

  • Open25.76
  • Day High25.87
  • Day Low24.77
  • Prev Close25.56
  • 52 Week High31.18
  • 52 Week High Date02/09/21
  • 52 Week Low9.70
  • 52 Week Low Date03/23/20
  • Market Cap2.958B
  • Shares Out117.31M
  • 10 Day Average Volume0.66M
  • Dividend-
  • Dividend Yield-
  • Beta0.86
  • 1 Year % Change86.12

RATIOS/PROFITABILITY

  • EPS (TTM)0.85
  • P/E (TTM)29.51
  • Fwd P/E (NTM)30.86
  • EBITDA (MRQ)128.727M
  • ROE (MRQ)23.70%
  • Revenue (MRQ)353.87M
  • Gross Margin (MRQ)98.42%
  • Net Margin (MRQ)29.96%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date05/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Corcept Therapeutics Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The Company is developing mifepristone, a compound that modulates the effects of cortisol by acting as a competitive antagonist at the glucocorticoid receptor (GR). As of December 31, 2016, it had discovered three structurally distinct series of selective cortisol...
James Wilson
Chairman
Joseph Belanoff M.D.
President
Gary Robb
Chief Financial Officer
J.D. Lyon
Chief Accounting Officer
Address
149 Commonwealth Dr
Menlo Park, CA
94025-1133
United States